ClinicalTrials.Veeva

Menu

PIEB Compared With CEI on Breakthrough Pain in Nulliparous Women

H

Holy Family Hospital, Nazareth, Israel

Status

Enrolling

Conditions

Breakthrough Pain

Treatments

Drug: programmed intermittent Bolus epidural analgesia
Drug: continuous epidural infusion

Study type

Interventional

Funder types

Other

Identifiers

NCT06494280
297\2024 HFH

Details and patient eligibility

About

The goal of this randomized controlled trial is to examine the impact of programmed intermittent bolus epidural analgesia technique on the incidence of breakthrough pain during labor in nulliparous women compared to continuous epidural infusion.

Nulliparous women will randomly be divided during labor into two groups; study group will receive mix of Bupivacaine and fentanyl once (bolus) every 60 minutes; the control group will receive continuously the same dose during an hour, until delivery.

Full description

There are several pharmacological and non-pharmacological techniques for pain relief during labor. Epidural analgesia is considered the most effective modality for intrapartum pain relief.

Maintenance of epidural analgesia is achieved by different techniques; continuous epidural infusion (CEI), intermittent epidural analgesia (IEA), patient control epidural analgesia (PCEA) and combination between the techniques.

Another technique, the Programmed Intermittent Bolus Epidural Analgesia (PIBEA). The advantage of this technique is that boluses are given all the time at planned intervals, so laboring women do not depend on the medical staff to receive the bolus when there is a breakthrough pain.

This method has been reported to be associated with less motor block, lower incidence of instrumental vaginal deliveries, and less consumption of anesthetic agents when compared to CEI. There are no conclusive data regarding the use of PIBEA in combination with PCEA compared to CEI and PCEA on the effect of pain relief during labor and birth outcomes. The hypothesis of the current trial is that PIBEA and PCEA will decrease the incidence of breakthrough pain, and probably shorten the second stage of labor, lead to fewer instrumental deliveries and higher women's satisfaction compared to CEI and PCEA.

Enrollment

240 estimated patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Nulliparous women
  • Term pregnancy
  • Singleton
  • Vertex presentation
  • Latent phase (cervical dilatation <6 cm)
  • Epidural analgesia request
  • Visual Analogue Scale score > 40

Exclusion criteria

  • Estimated fetal weight > 4 kg
  • Intra uterine fetal death
  • Drug sensitivity
  • Anomalous fetus
  • Contraindication for epidural analgesia

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

240 participants in 2 patient groups

study group
Active Comparator group
Description:
Epidural analgesia will be maintained by receiving programmed intermittent 10ml bolus of 0.1% Bupivacaine and 2microgram\\ml Fentanyl every one hour, until the delivery is completed, and lacerations are sutured.
Treatment:
Drug: programmed intermittent Bolus epidural analgesia
control group
Active Comparator group
Description:
Epidural analgesia will be maintained by receiving 10ml\\h continuous infusion of 0.1% Bupivacaine and 2microgram\\ml Fentanyl until the delivery is completed, and lacerations are sutured.
Treatment:
Drug: continuous epidural infusion

Trial contacts and locations

1

Loading...

Central trial contact

Raed Salim, MD; Asmaa Masri Esmail, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems